NCT00229216

Treatment of Bacterial Vaginosis With Oral Tinidazole

A Phase III Randomized, Multi-center, Double-blind, Double-dummy, Placebo-controlled Treatment Trial of Bacterial Vaginosis With Tinidazole Oral Tablets.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 200 (actual)
• Sponsor: Mission Pharmacal · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.

Detailed description

Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat bacterial vaginosis, one of the most common vaginal infections.

Conditions

• Bacterial Vaginosis

Interventions

Type	Name	Description
DRUG	Tinidazole

Timeline

• Start date: 2005-01-01
• Primary completion: 2007-06-01
• Completion: 2007-06-01
• First posted: 2005-09-29
• Last updated: 2017-03-22

Locations

1 site across 1 country: United States